Posted by Jeff Daas on Mar 5th, 2010 | No Comments
A new procedure for treating pancreatic and liver cancers using electrical fields to poke holes in tumors was used for the first time anywhere to fight pancreatic cancer at Stony Brook University Medical Center by Kevin Watkins, M.D., Chief of the Upper Gastrointestinal and General Oncologic Surgery Group…
Read Full Article
Posted by Jeff Daas on Mar 3rd, 2010 | No Comments
The Lustgarten Foundation announced that it has formed a national pancreatic cancer research consortium, a collaborative effort involving six world-renowned medical institutions to advance the most promising research initiatives aimed at finding a cure for pancreatic cancer…
Read Full Article
Posted by Jeff Daas on Mar 2nd, 2010 | No Comments
An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level…
Read Full Article
Posted by Jeff Daas on Feb 27th, 2010 | No Comments
As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient’s lifetime…
Read Full Article
Posted by Jeff Daas on Feb 27th, 2010 | No Comments
As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient’s lifetime…
Read Full Article
Posted by Jeff Daas on Feb 27th, 2010 | No Comments
As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient’s lifetime…
Read Full Article
Posted by Jeff Daas on Feb 27th, 2010 | No Comments
Researchers at the Mayo Clinic campus in Florida have found that PKC-iota (PKCι), an oncogene important in colon and lung cancers, is over-produced in pancreatic cancer and is linked to poor patient survival. They also found that genetically inhibiting PKCι in laboratory animals led to a significant decrease in pancreatic tumor growth and spread…
Read Full Article
Posted by Jeff Daas on Feb 27th, 2010 | No Comments
Expression of aldehyde dehydrogenase (ALDH) in pancreatic adenocarcinoma is associated with worse overall survival in patients who have undergone resection for early-stage disease, according to a new study published online February 17 in the Journal of the National Cancer Institute…
Read Full Article
Posted by Jeff Daas on Feb 27th, 2010 | No Comments
Physicians and scientists agree: If we cannot entirely prevent cancer, the next best thing is to find it earlier to augment the chances of a successful fight. The good news is that there may soon be a new weapon in the battle against the so-called “worst” cancer – cancer of the pancreas…
Read Full Article
Posted by Jeff Daas on Feb 15th, 2010 | No Comments
Researchers in the US have discovered that a protein known as disabled 2 (Dab2) triggers cancer spread by switching on the process that allows cancer cells to migrate from the original tumor site and establish new tumors in other parts of the body…
Read Full Article